Value Assessment and Health Outcomes Research Scientific Advisory Committee

Eberechukwu Onukwugha, MS, PhD (Co-Chair)

Professor , Dept. of Practice, Sciences & Health Outcomes Research
Executive Director, Pharmaceutical Research Computing
School of Pharmacy

University of Maryland School of Pharmacy

Junling Wang, PhD (Co-Chair)

Professor & Vice Chair for Research
Dept. of Clinical Pharmacy & Translational Science
College of Pharmacy

University of Tennessee

Aasthaa Bansal, PhD

Associate Professor
Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

University of Washington

Benjamin Craig, PhD

Associate Professor
Dept. of Economics

University of South Florida

Elizabeth Franklin, PhD, MSW

Head, US Public Affairs and Patient Advocacy, Oncology

Sanofi

Marianne Laouri, PhD

Global Asset Team Leader
Retinal Health

Boehringer Ingelheim Pharmaceuticals, Inc.

Pei-Jung “Paige” Lin, PhD

Associate Professor of Medicine
Center for the Evaluation of Value & Risk in Health
Institute for Clinical Research & Health Policy Studies

Tufts Medical Center

R. Brett McQueen, PhD

Associate Professor
Skaggs School of Pharmacy

University of Colorado

Philip Naughten, PharmD

Vice President, HEOR

Takeda

Christian Nguyen, PharmD, MBA, MS

Retired as Vice President, Global Patient Outcomes and Real World Evidence

Eli Lilly and Company

Megan O’Brien, PhD

Associate Vice President, CORE

Merck

Sarah E. Tom, PhD, MPH

Assistant Professor of Epidemiology

Columbia University

Gergana Zlateva, PhD

Vice President and Business Unit Lead
Oncology, Patient & Health Impact

Pfizer